Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
More than 2 million donut products recalled nationwide over listeria contamination risk FGF Brands has voluntarily recalled ...
Be cautious with your favorite pastries this week.
Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be short-lived deal ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
In response to complaints made publicly by the Partnership for Safe Medicine and the Obesity Society, Hims & Hers provided ...
The FDA did not specify which baked treats were recalled, but multiple outlets reported that the FGF Brands recall affected ...
Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to ...
A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results